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Abstract 
In the drug processing, many pharmaceutical candidates have to be thrown away 
due to their practical insolubility and low and erratic bioavailabilty. In recent years, 
there are numerous crystal engineering technology strategies for enhancing the 
bioavailability of drugs due to their low aqueous solubility. Engineering a poorly 
soluble drug into the nanocrystalline forms provides numerous routes to improve its 
bioavailability. So, it is of both scientific and industrial importance to develop 
advantageous engineering approaches, especially those safe, efficient, and green ones 
for drug delivery applications. Herein, we investigated a bio-inspired crystallization 
route to precipitate the "dumbbell-shaped" and "sea urchin" microspheres of a model 
drug – indomethacin (INN) with the high drug loading higher than 60%, where 
polyvinylpyrrolidone (PVP K30) or polyethylene imine (PEI600) as the additive. Then, 
the in-vitro drug release experiment evidenced that microspheres composed of 
nanocrystalline structural subunits had enhanced solubility and the dissolution rate 
compared with the raw indomethacin. Importantly, the time-resolved studies with the 
polarized optical microscopy, scanning electron microscopy, Raman spectroscopy 
revealed that the precipitation was a multistage process with the appearance of 
amorphous precursors and their transformation into the crystalline form. In addition, a 
multistage process was verified in the precipitation of L-histidine/polyacrylic-acid 
(L-His/PAA). These results not only enrich the understanding of non-classical organic 
crystallization, but also build the image of the transformation from liquid precursors 
to superstructures of nanocrystalline subunits. Finally, in a separate study, we 
designed the nacre-liked, light-weight L-His/PVA hybrid thin film via adjusting the 
mass ratio of the L-histidine nanoplatelets (L-His) and polyvinyl alcohol (PVA) and 
other experimental conditions. This could be the first full organic nacre-like 
bio-inspired product. 
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发生改变，从而使体系发生相分离。在 19 世纪末期，Gibbs 便已提出了相变自
由能（ΔGv）与表面能（ΔGs）的变化共同决定了形成晶核的自由能（ΔG）。其
体系自由能的变化为： 
ΔG=ΔGv +ΔGs = 4/3πr3Δgv +4πr2γ       （1-1） 
r*=-2γ/Δgv                           （1-2） 
ΔG — 晶核的自由能变化量； 
ΔGs — 表面自由能变化量； 
ΔGv — 体积自由能变化量； 
r — 晶核半径； 
Δgv — 两相间单位体积的自由能变化量； 
γ — 两相间的表面张力； 
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